Loading Events

« All Events

Virtual Event Virtual Event
  • This event has passed.

Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic

March 9, 2021 @ 11:00 am - March 10, 2021 @ 4:00 pm EST

Virtual Event Virtual Event

The National Academies will host a committee meeting on Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned from March 9-10, 2021.

Rapid (and Precise) COVID-19 Vaccine Development

Barney Graham, M.D., Ph.D., Deputy Director, Vaccine Research Center, NIAID, NIH

The COVID-19 Pandemic: The Triumphs and Challenges of Vaccine Development and Use of Animal Models in the Midst of a Pandemic

Ian Moore, D.V.M., Ph.D., DACVP, Investigative Veterinary Pathologist and Section Chief, Infectious Disease
Pathogenesis Section, NIAID, NIH

Bringing Together Stakeholders: Users and Resources

Franziska Grieder, D.V.M., Ph.D., Director, Office of Research Infrastructure Program, Division of Program Coordination, Planning, and Strategic Initiatives, NIH

Lessons Learned: NHP Supply

Kurt Derfler, M.B.A., Executive Director of Operations, Charles River Laboratories

Nonhuman Primate Importation During the SARS-CoV-2 Pandemic

Gale Galland, D.V.M., M.S., DACVPM, Veterinary Medical Officer, Zoonoses Team, Quarantine Border Health Services Branch, Division of Global Migration and Quarantine, CDC

Occupational Health in a Pandemic

Maureen Thompson, BSN, RN, COHN, RBP(ABSA), Safety Officer, Yerkes National Primate Research Center
Associate Director, Environmental Health and Safety Office, Emory University

Risk Assessment and Biosafety Support for SARS-CoV-2 and COVID-19 Research: Challenges in Established ABSL-2 and ABSL-3 Research Programs

Molly Stitt-Fisher, PhD, CPH, CBSP, SM(NRCM), Rebecca Lingenfelter, MSPH, University Biosafety, Officer/Associate Biosafety Officer and Alternate Responsible, Official for Select Agents, Department of Environmental Health and Safety, University of Pittsburgh

Public Messaging and Communications About Animal-Based Research During the COVID-19 Pandemic

James O’Reilly, B.A., President, Massachusetts Society for Medical Research

Virus Sequence Data During an Outbreak

Eneida Hatcher, Ph.D., Contractor, National Center for Biotechnology Information, National Library of Medicine,

The Nonhuman Primate Model of SARS-CoV-2 to Test Therapeutic Strategies: Overcoming Challenges and Obstacles Towards Proof of Concept

Koen Van Rompay, D.V.M., Ph.D., Full Research Virologist, California National Primate Research Center
UC Davis

Fast Tracking Animal Model Development, Collaborations, and Research to Deliver Preclinical Data for Vaccine Antigen Selection

Isis Kanevsky, Ph.D., Director, Vaccine Research Unit, Pfizer

Management of a Nonhuman Primate Colony During SARS-CoV-2

Joyce Cohen, V.M.D., DACLAM, Associate Director, Division of Animal Resources, Yerkes National Primate Research Center, Emory University

Maintaining Animal Research Continuity in the Time of COVID-19

Michael J. Huerkamp, D.V.M., DACLAM
Executive Director, Division of Animal Resources
Emory University

Resiliency in Animal Research Operations – COVID-19 Lessons Learned: Direct Staffing Impacts

CDR Temeri Wilder-Kofie, D.V.M., MPH, DACLAM, Facility Veterinarian, Comparative Medicine Branch, NIAID, NIH

Resiliency in Animal Research Operations: Laboratory Animal Program Operations and Management Impacts

Jill Ascher, M.A., D.V.M., MPH, DACLAM, Director, Division of Veterinary Resources, Office of Research Services

Impact of the COVID-19 Pandemic on Animal Research

Lori Palley, D.V.M., DACLAM, Assistant Director of Veterinary Services, Center for Comparative Medicine
Massachusetts General Hospital

Financial Impact of the COVID-19 Pandemic on Academic Animal Care Programs

Lucy Kennedy, D.V.M., DACLAM, Assistant Director for Clinical Services and Assistant Attending Veterinarian, Unit for Laboratory Animal Medicine, University of Michigan

Evolving Prioritizations of In Vivo Research in Pharma During the COVID-19 Pandemic

Sean Maguire, V.M.D., M.S., MRCVS, DACLAM, Comparative & Translational Sciences Director & Associate Fellow, GlaxoSmithKline

Integrating the Institution’s COVID-19 Response Plan into the Research Animal Program

Stephen Denny, D.V.M., M.S., DACLAM, DACVPM, Director, Office of Animal Care and Use Office of Intramural Research, NIH

Panel Discussion – Resiliency in Animal Research Operations
Open panel discussion with audience participation


  • Academia: Mike Huerkamp, Lucy Kennedy
  • Government: Jill Ascher, Temeri Wilder-Kofie, Stephen Denny
  • Industry – Pharma: Sean Maguire
  • Primate Research Center: Joyce Cohen
  • Animal Research Advocate: James O’Reilly

Meeting Materials

Please visit the Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned page for more information.


National Academies of Sciences, Engineering, and Medicine
View Organizer Website